Lupin Receives US FDA Tentative Approval for Dapagliflozin and Saxagliptin Tablets

On January 4, Indian generic drug company Lupin announced that its Dapagliflozin and Saxagliptin tablets received tentative approval from the U.S. Food and Drug Administration (FDA).